Heart-on-a-chip technology to combat heart disease
CompanyOctober 2018
Insilico Medicine, Rockville, USA(1)
TARA Biosystems Inc., Hong Kong, China(2)
TARA Biosystems Inc., Hong Kong, China(2)
The biotechnological companies Insilico Medicine and TARA Biosystems are working together using artificial intelligence and heart-on-a-chip technology to speed up drug discovery and lower drug cost in the fight against heart disease. Pairing artificial intelligence and heart-on-a-chip technology allows researchers to predict the therapeutic use of hundreds of
new drugs and test them on actual human heart cells before they enter clinical trials.
Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry
Alex Zhavoronkov(1), Misti Ushio(2)
Added on: 05-25-2020
[1] https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00930